Login to Your Account



Biotie Acquiring Elbion in $30M Cash, Shares Deal

By Cormac Sheridan


Wednesday, October 29, 2008
Biotie Therapies Oyj gained ownership of Elbion GmbH in a cash and shares deal valued at €24.4 million (US$30.4 million). (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription